Axatilimab (INCA034176)
INCA034176-355
Phase 3 small_molecule active
Quick answer
Axatilimab (INCA034176) for Chronic Graft-Versus-Host Disease is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- Chronic Graft-Versus-Host Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active